Engineered bacteria assist CAR-cell immunotherapy
Acta Pharmaceutica Sinica B · 2025-03 · 15 (3) · 1703-1705
DOI: 10.1016/j.apsb.2025.01.020 ↗Kurz gefasst
Leserbrief in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-03. Verfasst von Tianyu Shao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China Stem Cell and Translational Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China Stem Cell and Translational Research
Zitieren
APA
Shao, T., Xu, M., Li, J., & Zhao, X. (2025). Engineered bacteria assist CAR-cell immunotherapy. Acta Pharmaceutica Sinica B, 15(3), 1703-1705. https://doi.org/10.1016/j.apsb.2025.01.020
Vancouver
Shao T, Xu M, Li J, Zhao X. Engineered bacteria assist CAR-cell immunotherapy. Acta Pharmaceutica Sinica B. 2025;15(3):1703-1705. doi:10.1016/j.apsb.2025.01.020
BibTeX
@article{Shao2025,
author = {Shao, Tianyu and Xu, Manman and Li, Jie and Zhao, Xiao},
title = {Engineered bacteria assist CAR-cell immunotherapy},
journal = {Acta Pharmaceutica Sinica B},
year = {2025},
volume = {15},
number = {3},
pages = {1703--1705},
doi = {10.1016/j.apsb.2025.01.020}
}
EUVIMED